Commercialization Option definition

Commercialization Option means an option granted by Numab to Sucampo to enter into a Commercialization Agreement with respect to a Compound according to the terms as set forth below in Section 6.2.
Sample 1Sample 2
Commercialization Option means the option granted by BACH to POINT in accordance with Section 3.1 upon which exercise POINT is granted the worldwide royalty bearing exclusive license to the Licensed Patents, Licensed Know-How and Licensed Materials for the Field. 2.8 “Commercially Reasonable Efforts” means exerting such efforts and employing such resources on a consistent basis throughout the Term as would normally be exerted or employed by an entity having similar resources to POINT with respect to products that are similar to the Licensed Products (including by having similar market potential, profit potential and strategic value, being at a similar stage of its product life), taking into account, without limitation, issues of safety and efficacy, product profile, intellectual property situation, pricing and reimbursement, the competitiveness of the relevant marketplace, the issuance of Licensed Patents, intellectual property and development positions of third parties impacting on freedom-to-operate, the applicable regulatory situation, the commercial viability of the Licensed Product and other relevant development and commercialization factors based upon then-prevailing conditions, but excluding from consideration any financial obligations of POINT to BACH under this Agreement. 2.9 “Confidential Information” means all non-public scientific, technical, financial or business information which is disclosed by one Party to the other Party. Confidential Information of a disclosing Party may include third party information. Confidential Information that is developed jointly by the Parties shall be “Confidential Information” of both of the Parties. 2.10 “Controlled” (or “Controls”) means with respect to any intellectual property or other data, information or materials, possession of the ability by a Party or its Affiliate(s) to grant, without violating the terms of any agreement with a Third Party, a license, access or other right in, to or under such intellectual property or other data, information or materials on the relevant terms provided herein. 2.11 “Collaboration Activities” means the activities to be undertaken by each of the Parties as detailed in the Sponsored Research Agreement and any Work Plan(s) as defined in the Sponsored Research Agreement; 2.12 “Collaboration Patent Rights” refers to patent and patent applications arising from inventions made by employees, consultants and contractors of the Parties or by employees of Tufts
Sample 1
Commercialization Option means the option granted by BACH to POINT in accordance with Section 3.1 upon which exercise POINT is granted the worldwide
Sample 1

Examples of Commercialization Option in a sentence

  • Documentation for the Phase II Commercialization Option are receipts showing that at least $100,000 was transferred to the contractor from one or more third party investors, such as a venture capital firm, an individual "angel" investor, state or local funding source, or another company under a partnership, licensing or joint venture arrangement, or any combination of third parties.

  • Each Development and Commercialization Option will be exercisable as to a particular Candidate Compound during the Research Term.

  • The JSC will be responsible for overseeing the Research Collaboration and the Research Programs, Phase I Clinical Trials, Phase I/II Clinical Trials, and Phase II Clinical Trials (for so long as Codiak or its Affiliates are conducting such trials), and any Development after the exercise by Codiak of its Development and Commercialization Option, and will oversee the activities under the Co-Promotion Agreement(s), if applicable, as set forth below.

  • Within ten (10) Business Days of each exercise by Sanofi of a Development and Commercialization Option, Sanofi will pay to Rib-X an option exercise fee in the amount of US $[***] per [***] (and the [***]) as to which the relevant Development and Commercialization Option was exercised (the “Option Exercise Fee”).

  • Notwithstanding the foregoing, Codiak’s Development and Commercialization Option shall be deemed not exercised in respect of a Licensed Product if Jazz notifies Codiak within [***] of receipt of such notice from Codiak that Jazz is exercising its veto right with respect to such Licensed Product, which right may be exercised by Jazz with respect to only one Licensed Product.

  • The date, if any, on which Sanofi has properly exercised its Development and Commercialization Option in accordance with the preceding sentence will be the “Option Exercise Date” for such Licensed Compound for purposes of this Agreement.

  • In the event Sanofi elects to exercise its Development and Commercialization Option as to a particular Candidate Compound, Sanofi will, no later than the close of business on the last day of the Research Term, deliver to Rib-X (i) a written notice specifying that Sanofi has elected to exercise its Development and Commercialization Option as to such Candidate Compound (the “Option Exercise Notice”) and (ii) payment in full of the Option Exercise Fee for such Candidate Compound.

  • In addition, for each Candidate Compound as to which Sanofi has exercised its Development and Commercialization Option under the preceding sentence, Sanofi will be entitled to designate two Back-up Compounds to such Candidate Compound to include as Licensed Compounds, such designation to be made by written notice given to Rib-X at any time during the Research Term or Follow-on Period.

  • In addition to the rights set forth above in this Section 2.8, during the [***] of the Research Term, all Target Compounds shall be deemed Candidate Compounds, thereby allowing Sanofi to exercise its Development and Commercialization Option on all such compounds and receive the license set forth in Section 4.2.1 for any such Target Compound as to which Sanofi exercises its Development and Commercialization Option prior to the end of the Research Term.

  • For each Optioned Product, Codiak shall be responsible for Development Costs as and to the extent set forth in Section 8.4, including any start-up costs associated therewith whether occurring prior to or after the exercise of the applicable Development and Commercialization Option.


More Definitions of Commercialization Option

Commercialization Option. License Agreement," "Products," and "Research Field of Use" as defined below);
Sample 1
Commercialization Option shall have the meaning set forth in Section 4.2.1 hereof.
Sample 1
Commercialization Option shall have the meaning set forth in Section 4.2.1 of the Collaboration Agreement.
Sample 1
Commercialization Option shall have the meaning as set forth in Section 6.1.
Sample 1

Related to Commercialization Option

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Development Program means the implementation of the development plan.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Development Plan has the meaning set forth in Section 3.2.

  • Collaboration Term has the meaning set forth in Section 2.1(h).

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • License Period means the period beginning from the Commencement Date and ending on the Termination Date.

  • Commercialise means to promote, market, distribute, sell and/or otherwise commercialise a product, and Commercialising and Commercialisation shall be construed accordingly;

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Milestone is defined in Section 5.3.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Commercialize or “Commercialization” means the marketing, promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation (including pricing and reimbursement activities) for a Product in the Territory. Commercialization shall include commercial activities conducted in preparation for Product launch.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Licensed Territory means worldwide.

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 3.4 (Joint Commercialization Committee).

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).